104 related articles for article (PubMed ID: 1720180)
41. Identification of a potent synthetic HIV1 immunogen compromising gag-P24 tandem T- and B-cell epitopes.
Chong P; Sia C; Sydor M; Klein M
FEBS Lett; 1990 May; 264(2):231-4. PubMed ID: 1694143
[TBL] [Abstract][Full Text] [Related]
42. Immunological reactivities of Ghanaian sera with HIV-1, HIV-2, and simian immunodeficiency virus SIVagm.
Kawamura M; Ishikawa K; Mingle JA; Osei-Kwasi M; Afoakwa SN; Nettey VB; Chosa T; Hayami M
AIDS; 1989 Sep; 3(9):609-11. PubMed ID: 2551342
[TBL] [Abstract][Full Text] [Related]
43. Fine molecular specificity of linear and assembled antibody binding sites in HIV-1 p24.
Haaheim LR; Maskell JP; Mascagni P; Coates AR
Scand J Immunol; 1991 Sep; 34(3):341-50. PubMed ID: 1715604
[TBL] [Abstract][Full Text] [Related]
44. Hypervariable epitope constructs representing variability in envelope glycoprotein of SIV induce a broad humoral immune response in rabbits and rhesus macaques.
Meyer D; Anderson DE; Gardner MB; Torres JV
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):751-60. PubMed ID: 9643375
[TBL] [Abstract][Full Text] [Related]
45. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
[TBL] [Abstract][Full Text] [Related]
46. T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals.
Pinto LA; Covas MJ; Victorino RM
J Med Virol; 1995 Oct; 47(2):139-44. PubMed ID: 8830117
[TBL] [Abstract][Full Text] [Related]
47. [Study of antigenic structure of HIV-1 protein p24 using monoclonal antibodies].
Konovalov EE; Loktev VB; Pokrovskiĭ AG; Fediuk NV; Chernykh AI; Nechaev IuS; Kuliandin SA; Kipriianov SM; Ofitserov VI
Vestn Ross Akad Med Nauk; 1992; (9-10):55-9. PubMed ID: 1283723
[TBL] [Abstract][Full Text] [Related]
48. Cross-reactivity with SIVmac in east African HIV-1-positive sera: evidence against double infection with HIV-1 and a SIVmac/HIV-2-like virus.
Blomberg J; Klasse PJ; Pehrson C
Intervirology; 1990; 31(5):276-84. PubMed ID: 1703133
[TBL] [Abstract][Full Text] [Related]
49. Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity.
Mills KH; Barnard AL; Williams M; Page M; Ling C; Stott EJ; Silvera P; Taffs F; Kingsman AS; Adams SE
J Immunol; 1991 Nov; 147(10):3560-7. PubMed ID: 1719081
[TBL] [Abstract][Full Text] [Related]
50. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
Nakaya Y; Zheng H; García-Sastre A
Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
[TBL] [Abstract][Full Text] [Related]
51. DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
Hu X; Valentin A; Dayton F; Kulkarni V; Alicea C; Rosati M; Chowdhury B; Gautam R; Broderick KE; Sardesai NY; Martin MA; Mullins JI; Pavlakis GN; Felber BK
J Immunol; 2016 Nov; 197(10):3999-4013. PubMed ID: 27733554
[TBL] [Abstract][Full Text] [Related]
52. Characterization of antibodies reacting with HIV gag proteins occasionally found in the serum of non-infected subjects.
Bürgisser P; Frei PC
Clin Exp Immunol; 1991 Aug; 85(2):219-23. PubMed ID: 1713811
[TBL] [Abstract][Full Text] [Related]
53. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
54. Characterization of monoclonal antibodies against the p17 core protein of the human immunodeficiency virus 1.
Cogniaux J; De Schepper N; Blondiau ML; Cornet B; Horal P; Vahlne A
J Immunol Methods; 1990 Apr; 128(2):165-75. PubMed ID: 1691236
[TBL] [Abstract][Full Text] [Related]
55. A peptide library expressed in yeast reveals new major epitopes from human immunodeficiency virus type 1.
Madaule P; Gairin JE; Bénichou S; Rossier J
FEMS Microbiol Immunol; 1991 Apr; 3(2):99-107. PubMed ID: 1713777
[TBL] [Abstract][Full Text] [Related]
56. Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag.
Zhao J; Voltan R; Peng B; Davis-Warren A; Kalyanaraman VS; Alvord WG; Aldrich K; Bernasconi D; Buttò S; Cafaro A; Ensoli B; Robert-Guroff M
Virology; 2005 Nov; 342(1):1-12. PubMed ID: 16109434
[TBL] [Abstract][Full Text] [Related]
57. Immunological characterization and detection of the major core protein p24 of the human immunodeficiency virus (HIV) using monoclonal antibodies.
Kusk P; Ulrich K; Zeuthen J; Pallesen G
J Acquir Immune Defic Syndr (1988); 1988; 1(4):326-32. PubMed ID: 2464053
[TBL] [Abstract][Full Text] [Related]
58. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
[TBL] [Abstract][Full Text] [Related]
59. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
[TBL] [Abstract][Full Text] [Related]
60. Major antigenic domain recognized by monoclonal antibodies maps within the carboxy-terminal moiety of a recombinant human immunodeficiency virus-1 p24 protein.
Gallina A; Rossi F; Mariani M; Bonelli F; Achilli G; Cattaneo E; Milanesi G
J Med Virol; 1990 Nov; 32(3):164-70. PubMed ID: 1704049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
